AI assistant
Sending…
RxSight, Inc. — Director's Dealing 2026
Mar 3, 2026
33077_dirs_2026-03-03_90e8a6fa-ea93-43e5-8c63-afe2ab362b8d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RxSight, Inc. (RXST)
CIK: 0001111485
Period of Report: 2026-02-28
Reporting Person: Wilterding Mark (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-28 | Common Stock | M | 20441 | — | Acquired | 20441 | Direct |
| 2026-02-28 | Common Stock | F | 8068 | $7.61 | Disposed | 12373 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-28 | Restricted Stock Unit | $ | M | 20441 | Disposed | Common Stock (20441) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one eighth (1/8th) of the shares subject to the RSU award vested on February 28, 2026, and one eighth (1/8th) of the shares subject to the RSU award will vest every six months thereafter on the last day of February and the last day of August over a four-year period.
More from RxSight, Inc.
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 25
Regulatory Filings
2026
Feb 25
Major Shareholding Notification
2026
Feb 3
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30